Both in Pharmaceuticals
Celularity vs Briacell Therapeutics
Over the past year CELU returned −53.2% and BCTX returned −69.3%; their daily moves had a correlation of 0.03.
CELU −53.2% BCTX −69.3%Growth of $1, one year, split-adjusted
| Metric | CELU | BCTX |
|---|---|---|
| Price | $0.8042 | $3.07 |
| Market cap | $26.1M | $26.8M |
| Today | +0.21% | −0.81% |
| 1 month | −53.0% | −26.7% |
| 6 months | −15.6% | −24.7% |
| Year to date | −27.5% | −56.9% |
| 1 year | −58.8% | −72.1% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 56.8% | — |
| Net margin | 10.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | — |
| Net cash | -$37.1M | $20.5M |
| Dividend yield | — | — |
| Volatility (60d) | 223.1% | 75.9% |
| Short % of float | 6.7% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).